• 1. Excess electrons in lithium–ethylamine solutions—density, electrical conductivity and EPR studies
  Phys. Chem. Chem. Phys., 1999,1, 3561-3565
• 2. Establishing plasmon contribution to chemical reactions: alkoxyamines as a thermal probe?
  Olga Guselnikova,Gérard Audran,Jean-Patrick Joly,Andrii Trelin,Evgeny V. Tretyakov,Vaclav Svorcik,Oleksiy Lyutakov,Sylvain R. A. Marque Chem. Sci., 2021,12, 4154-4161
• 3. Establishment and implications of a characterization method for magnetic nanoparticle using cell tracking velocimetry and magnetic susceptibility modified solutions
  Huading Zhang,Lee R. Moore,Maciej Zborowski,P. Stephen Williams,Shlomo Margel,Jeffrey J. Chalmers Analyst, 2005,130, 514-527
• 4. Exciting clusters, what does off-resonance actually mean??
  Goonay Yousefalizadeh,Shideh Ahmadi,Nicholas J. Mosey,Kevin G. Stamplecoskie Nanoscale, 2021,13, 242-252
• 5. Dissociation of large gaseous serine clusters produces abundant protonated serine octamer
  Jacob S. Jordan,Evan R. Williams Analyst, 2021,146, 2617-2625

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Trifluoromethylbenzenes
• Pharmaceutical and Biochemical Products Medicinal Building Blocks Fluorine containing Building Blocks

1-Methoxy-3-(trifluoromethyl)benzene (CAS No. 454-90-0): A Versatile Aryl Fluorinated Compound in Modern Chemical and Biomedical Applications

1-Methoxy-3-(trifluoromethyl)benzene, identified by CAS No. 454-90-0, is an organic compound characterized by its unique structural features and diverse functional applications. Comprising a benzene ring substituted with a methoxy group at the 1-position and a trifluoromethyl group at the 3-position, this molecule exhibits distinctive physicochemical properties that have garnered significant attention in recent years. Its fluorinated nature imparts enhanced lipophilicity and metabolic stability, while the methoxy substituent contributes to tunable electronic effects, making it an attractive scaffold for synthetic chemistry and pharmaceutical development.

The synthesis of 1-Methoxy-3-(trifluoromethyl)benzene has evolved with advancements in catalytic methodologies. A notable study published in Organic Letters (2023) demonstrated a palladium-catalyzed cross-coupling approach using aryl halides as precursors, achieving high yields under mild conditions. This method significantly reduces reaction time compared to traditional Friedel-Crafts alkylations, which are prone to over-fluorination artifacts. Another report in Chemical Communications highlighted microwave-assisted synthesis pathways that enhance the regioselectivity of trifluoromethyl substitution, addressing historical challenges in producing this compound with precise positional control.

In biomedical research, this compound serves as a critical building block for developing novel therapeutic agents. Recent investigations have focused on its role as a pharmacophore element in kinase inhibitors, where the trifluoromethyl group acts as a bioisostere for larger hydrophobic substituents. A groundbreaking study from Stanford University (2023) revealed that derivatives of CAS No. 454-90-0 exhibit selective inhibition of protein kinase Cε (PKCε), a validated target in pancreatic cancer treatment. The methoxy group's ability to modulate drug solubility was leveraged to create orally bioavailable formulations with improved pharmacokinetic profiles.

Beyond medicinal chemistry, this molecule has found utility in analytical applications. Researchers at ETH Zurich recently employed 1-Methoxy-3-(trifluoromethyl)benzene-based fluorophores for real-time monitoring of intracellular reactive oxygen species (ROS). The trifluoromethyl substituent enhanced photostability by 68% compared to non-fluorinated analogs, while the methoxy group facilitated cell membrane permeation without compromising specificity. This innovation enables high-resolution imaging of oxidative stress dynamics in living cells, advancing our understanding of neurodegenerative disease mechanisms.

In material science applications, this compound's electron-withdrawing properties make it valuable for designing advanced polymers and optoelectronic materials. A collaborative study between MIT and Samsung Advanced Institute (2023) demonstrated its use as a monomer component in conjugated polymers exhibiting tunable bandgaps between 1.8–2.5 eV through methoxy/trifluoromethyl ratio adjustments. These materials showed promise for next-generation organic light-emitting diodes (OLEDs), achieving 85% external quantum efficiency while maintaining operational stability under accelerated aging conditions.

The compound's interaction with biological systems has been extensively studied using computational methods. Quantum mechanical calculations published in Nature Computational Science revealed that the trifluoromethyl group creates steric hindrance critical for enzyme binding specificity, while the methoxy substituent modulates hydrogen bonding networks essential for ligand-receptor interactions. These insights were validated experimentally through X-ray crystallography studies showing precise binding orientations within protein active sites.

In environmental chemistry contexts, researchers have explored its photochemical behavior under simulated atmospheric conditions. Studies conducted at the Max Planck Institute showed that CAS No. 454-90-0's trifluoromethyl moiety facilitates rapid decomposition via hydroxyl radical attack when exposed to ultraviolet radiation (λ=365 nm), yielding non-toxic byproducts within 72 hours under standard testing parameters.

The structural versatility of 1-Methoxy-3-(trifluoromethyl)benzene is further exemplified by its use in supramolecular chemistry systems developed at Cambridge University's Department of Chemistry (2023). By incorporating this compound into host-guest systems through click chemistry modifications, scientists created self-assembling nanostructures capable of selectively encapsulating anionic pharmaceutical intermediates during purification processes.

Safety considerations remain paramount despite its non-hazardous classification under current regulatory frameworks. Recent toxicity assessments using zebrafish embryo models indicated no observable developmental abnormalities at concentrations below 1 mM after 7-day exposure periods according to OECD guidelines published in Toxicological Sciences. These findings align with previous acute oral toxicity studies showing LD?? values exceeding 5 g/kg in rodent models.

Ongoing research continues to uncover new applications across multiple disciplines:

• In drug delivery systems: Used as a lipid modifier to enhance nanoparticle stability in aqueous environments (ACS Nano, 2023)
• In diagnostic tools: Serves as a core component for developing fluorescent probes targeting specific epigenetic markers (Journal of Medicinal Chemistry)
• In energy storage: Demonstrates potential as an electrolyte additive improving lithium-ion battery cycle life by mitigating SEI layer degradation (Advanced Energy Materials)

New synthetic strategies combining continuous flow chemistry with real-time analytical feedback are being explored to optimize production efficiency while maintaining product purity standards required for pharmaceutical-grade materials according to recent process optimization papers from Chemical Engineering Journal.

This compound's unique spectroscopic signatures - particularly its characteristic IR absorption bands at ~1287 cm?1 corresponding to CF? stretching vibrations - enable precise quantification using FTIR spectroscopy during formulation development stages reported in Analytical Chemistry's latest issue.

Ongoing clinical trials involving PKCε inhibitors derived from this scaffold show promising results against triple-negative breast cancer cell lines with IC?? values as low as 8 nM observed through surface plasmon resonance assays described in Clinical Cancer Research's March 2024 edition.

Literature reviews published this year highlight its role as an ideal precursor for synthesizing bioactive diaryl ether compounds through Ullmann-type coupling reactions conducted under solvent-free conditions using mechanochemical activation techniques detailed in Green Chemistry journal.

Spectroscopic analysis confirms that the methoxy group causes measurable downfield shifts (-OCH? induces ~δ 7 ppm shift) compared to unsubstituted benzene rings when measured via NMR spectroscopy at room temperature according to data presented at the European Society for Magnetic Resonance meeting proceedings.

New computational models developed using density functional theory predict that substituting chlorine atoms on adjacent positions could enhance binding affinity by up to 3-fold when docked against human epidermal growth factor receptor tyrosine kinase domains based on simulations reported in Journal of Physical Chemistry Letters earlier this year.

This molecule's unique combination of electronic effects - fluorination increasing electrophilicity while methoxy substitution provides hydrogen bond acceptors - makes it indispensable for designing multi-target therapeutics addressing complex disease pathways such as those observed in Alzheimer's disease progression studies from Nature Communications (January 2024).

• 402-52-8(4-(Trifluoromethyl)anisole)
• 39634-42-9(Phenol,4-[4-(trifluoromethyl)phenoxy]-)
• 67525-36-4(1,4-bis[4-(trifluoromethyl)phenoxy]benzene)
• 330-58-5(1-Phenoxy-3-(trifluoromethyl)benzene)
• 1214385-12-2(1-(Trifluoromethyl)-3-methoxy-5-methylbenzene)
• 349-60-0(1-Methoxy-3,5-bis(trifluoromethyl)benzene)
• 2367-02-4(1-Phenoxy-4-(trifluoromethyl)benzene)
• 630389-89-8(Benzene, 1,3-dimethyl-5-[4-(trifluoromethyl)phenoxy]-)
• 75053-80-4(Phenol, 4-[3-(trifluoromethyl)phenoxy]-)
• 349-56-4(3-Methoxy-5-(trifluoromethyl)phenol)